News Conference News ESC 2024 Asundexian for AF? More Details on the Sinking of OCEANIC-AF Shelley Wood September 02, 2024
News Conference News ACC 2024 Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI Yael L. Maxwell April 06, 2024
News Conference News AHA 2023 MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia L.A. McKeown November 11, 2023
News Conference News ESC 2020 New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials Caitlin E. Cox September 03, 2020
News Conference News CRT 2019 Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis Yael L. Maxwell March 03, 2019
News Conference News CRT 2019 New ALERTS Data Support Use of Implantable Cardiac Monitor in High-Risk ACS Patients—With Caveats Yael L. Maxwell March 03, 2019
News Conference News TCT 2018 ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year Lucy Hicks September 24, 2018
News Conference News HRS 2018 CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation Todd Neale May 10, 2018
News Conference News SCAI 2017 #SoMe for #SciComm? Cardiologists See Value in Social Media, With Some Caveats L.A. McKeown May 10, 2017
News Conference News ACC 2017 ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s Yael L. Maxwell March 17, 2017
News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
News Conference News AHA 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Conference News ACC 2015 Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI Yael L. Maxwell March 15, 2015
News Conference News ACC 2012 Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism L.A. McKeown March 26, 2012
News Conference News Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients November 08, 2011